Manish R Patel

Manish R Patel

UNVERIFIED PROFILE

Are you Manish R Patel?   Register this Author

Register author
Manish R Patel

Manish R Patel

Publications by authors named "Manish R Patel"

Are you Manish R Patel?   Register this Author

78Publications

2356Reads

12Profile Views

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models.

Cancer Gene Ther 2019 Nov 9;26(11-12):411-418. Epub 2019 Jan 9.

Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41417-018-0074-6
Publisher Site
http://dx.doi.org/10.1038/s41417-018-0074-6DOI Listing
November 2019

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.

J Immunother Cancer 2019 01 16;7(1):12. Epub 2019 Jan 16.

Genitourinary Malignancies Branch and Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0
Publisher Site
http://dx.doi.org/10.1186/s40425-018-0459-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335739PMC
January 2019

A review of avelumab in locally advanced and metastatic bladder cancer.

Ther Adv Urol 2019 Jan-Dec;11:1756287218823485. Epub 2019 Jan 30.

University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287218823485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354303PMC
January 2019

A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER/HER2 Advanced Breast Cancer.

Clin Cancer Res 2018 08 13;24(15):3510-3518. Epub 2018 Feb 13.

Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3102DOI Listing
August 2018

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials.

Cancer 2018 05 22;124(9):2010-2017. Epub 2018 Feb 22.

Genitourinary Malignancies Branch, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947549PMC
May 2018

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.

Invest New Drugs 2018 04 8;36(2):217-229. Epub 2017 Nov 8.

Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0535-zDOI Listing
April 2018

Immunotherapy for thoracic oncology gone viral.

Authors:
Manish R Patel

Immunotherapy 2018 04;10(5):383-390

Department of Medicine, Division of Hematology, Oncology, & Transplantation, University of Minnesota Medical Center, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0148DOI Listing
April 2018

A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors.

Onco Targets Ther 2018 30;11:2399-2407. Epub 2018 Apr 30.

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S157331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935192PMC
April 2018

Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia.

Blood 2018 03 5;131(11):1258-1261. Epub 2018 Feb 5.

Department of Malignant Hematology and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-11-819276DOI Listing
March 2018

Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy- a report of two cases.

J Immunother Cancer 2016 15;4:80. Epub 2016 Nov 15.

University of Minnesota, 420 Delaware St SE, MMC 480, Minneapolis, MN 55455 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0185-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109681PMC
February 2018

Water induced sediment levitation enhances downslope transport on Mars.

Nat Commun 2017 10 27;8(1):1151. Epub 2017 Oct 27.

School of Physical Sciences, Faculty of Science, Technology, Engineering & Mathematics, The Open University, Walton Hall, Milton Keynes, MK7 6AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-01213-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658360PMC
October 2017

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.

J Clin Oncol 2017 Jul 4;35(19):2117-2124. Epub 2017 Apr 4.

Andrea B. Apolo and James L. Gulley, National Institutes of Health, Bethesda, MD; Jeffrey R. Infante, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Ani Balmanoukian, The Angeles Clinic & Research Institute; Alain C. Mita, Cedars Sinai Medical Center, Los Angeles; Karen Kelly, University of California-Davis, Sacramento; Marko Srdanov, Dako North America, Carpinteria, CA; Manish R. Patel, Florida Cancer Specialists & Research Institute, Sarasota, FL; Ding Wang, Henry Ford Hospital, Detroit, MI; Anthony E. Mega, The Warren Alpert Medical School at Brown University; Howard Safran, The Miriam Hospital, Providence; Howard Safran, Newport Hospital, Newport, RI; Carolyn D. Britten, Medical University of South Carolina, Charleston, SC; Alain Ravaud, CHU de Bordeaux, Bordeaux, France; Thomas E. Stinchcombe, Duke University Medical Center, Durham, NC; Arnold B. Gelb and Kevin Chin, EMD Serono, Billerica, MA; and Michael Schlichting, Merck, Darmstadt, Germany.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.6795
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.6795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493051PMC
July 2017

Viroimmunotherapy of Thoracic Cancers.

Biomedicines 2017 Jan 4;5(1). Epub 2017 Jan 4.

Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biomedicines5010002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423488PMC
January 2017

Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.

J Clin Oncol 2016 10;34(29):3562-3569

Aung Naing, Rivka R. Colen, David S. Hong, and Nizar M. Tannir, MD Anderson Cancer Center, Houston; Kyriakos P. Papadopoulos and Drew R. Rasco, START Center for Cancer Care, San Antonio, TX; Karen A. Autio, Memorial Sloan Kettering Cancer Center, New York, NY; Patrick A. Ott, Dana-Farber Cancer Institute, Boston, MA; Manish R. Patel, Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL; Deborah J. Wong, University of California Los Angeles, Los Angeles; Melinda Whiteside, John B. Mumm, Ivan H. Chan, Peter Van Vlasselaer, and Martin Oft, ARMO BioSciences, Redwood City, CA; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Shubham Pant, Oklahoma University, Oklahoma City, OK; and Johanna C. Bendell, Todd M. Bauer, and Jeffrey R. Infante, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657013PMC
October 2016

Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2016 06 5;77(6):1275-83. Epub 2016 May 5.

Sarah Cannon Research Institute UK, 93 Harley Street, London, W1G 6AD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3031-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882359PMC
June 2016

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

Cancer Chemother Pharmacol 2016 Feb;77(2):439

Sarah Cannon Research Institute/Florida Cancer Specialists, 600 N. Cattlemen Road, Suite 200, Sarasota, FL, 34232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2890-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969883PMC
February 2016

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

Cancer Chemother Pharmacol 2015 Nov 14;76(5):925-32. Epub 2015 Sep 14.

Sarah Cannon Research Institute/Florida Cancer Specialists, 600 N. Cattlemen Road, Suite 200, Sarasota, FL, 34232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2850-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612319PMC
November 2015

Targeting Topoisomerase II Activity in NSCLC with 9-Aminoacridine Derivatives.

Anticancer Res 2015 Oct;35(10):5211-7

Department of Medicine, University of Minnesota, Minneapolis, MN, U.S.A.

View Article

Download full-text PDF

Source
October 2015

Endometrial metastasis of lung adenocarcinoma: a report of two cases.

Am J Case Rep 2015 May 18;16:296-9. Epub 2015 May 18.

Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://www.amjcaserep.com/abstract/index/idArt/892495
Publisher Site
http://dx.doi.org/10.12659/AJCR.892495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444144PMC
May 2015

Targeting PI3 kinase in cancer.

Pharmacol Ther 2015 Feb 18;146:53-60. Epub 2014 Sep 18.

Sarah Cannon Research Institute, Nashville, TN, USA; Tennessee Oncology, PLLC, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2014.09.006DOI Listing
February 2015

Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells.

Invest New Drugs 2014 Aug 9;32(4):598-603. Epub 2014 Apr 9.

Department of Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0076-7DOI Listing
August 2014

Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.

J Thorac Oncol 2014 Aug;9(8):1101-10

*Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis; and †Department of Molecular Medicine, Mayo Clinic Medical Center, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145613PMC
August 2014

Resistance to EGFR-TKI can be mediated through multiple signaling pathways converging upon cap-dependent translation in EGFR-wild type NSCLC.

J Thorac Oncol 2013 Sep;8(9):1142-7

Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31829ce963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745544PMC
September 2013

Oncolytic virus therapy for cancer: the first wave of translational clinical trials.

Transl Res 2013 Apr 10;161(4):355-64. Epub 2013 Jan 10.

Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, Minn., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2012.12.010DOI Listing
April 2013

Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis.

Invest New Drugs 2012 Aug 26;30(4):1443-8. Epub 2011 Jul 26.

Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, University of Minnesota, Minneapolis, MN 55414, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-011-9720-7
Publisher Site
http://dx.doi.org/10.1007/s10637-011-9720-7DOI Listing
August 2012

Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation.

Int J Oncol 2012 Feb 4;40(2):577-82. Epub 2011 Nov 4.

University of Minnesota Medical School, Division of Hematology, Oncology, and Transplantation, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2011.1252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478613PMC
February 2012

Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.

Arch Pathol Lab Med 2011 Mar;135(3):365-71

Hematology-Oncology Section, Departments of Medicine, Veterans Administration Medical Center, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/2009-0759-OA.1DOI Listing
March 2011

Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II.

Invest New Drugs 2010 Feb 10;28(1):20-5. Epub 2009 Jan 10.

Division of Hematology-Oncology-Transplant, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-008-9209-1
Publisher Site
http://dx.doi.org/10.1007/s10637-008-9209-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597882PMC
February 2010

Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy.

Mol Ther 2008 Nov 2;16(11):1848-56. Epub 2008 Sep 2.

Department of Molecular and Medical Pharmacology, University of California at Los Angeles (UCLA) School of Medicine, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2008.180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195556PMC
November 2008

Ras pathway activation in malignant mesothelioma.

J Thorac Oncol 2007 Sep;2(9):789-95

Division of Hematology-Oncology-Transplant, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31811f3aabDOI Listing
September 2007

Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award.

Ann Thorac Surg 2006 Sep;82(3):996-1001; discussion 1001-2

Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2006.04.013DOI Listing
September 2006

Radiative habitable zones in martian polar environments.

Icarus 2005 Jun;175(2):360-71

Instituto Nacional de Técnica Aeroespacial (INTA), Area de Investigación e Instrumentación Atmosférica, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.icarus.2004.12.009DOI Listing
June 2005

Solar UV irradiation conditions on the surface of Mars.

Photochem Photobiol 2003 Jan;77(1):34-40

MTA-SE Research Group for Biophysics, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1562/0031-8655(2003)077<0034:suicot>2.0.co;2DOI Listing
January 2003

Indomethacin, dexamethasone, and intestinal damage in infant rats.

J Pediatr Gastroenterol Nutr 2002 Aug;35(2):154-61

Division of Neonatology, Department of Pediatrics, J Hillis Miller Health Center, University of Florida College of Medicine, Gainesville, Florida 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00005176-200208000-00010DOI Listing
August 2002